Entries in Contrave (2)


New Weight-Loss Drug Wins Initial Approval

File Photo Courtesy -- Getty Images(WASHINGTON) – An FDA panel has recommended approval of the investigative weight-loss drug Contrave, even after two such drugs up for approval in 2010 were rejected.

The panel voted 13-to-7 to give Contrave the green light, despite blood pressure risks associated with the drug.

The FDA has until January to decide whether to approve the drug. Two other weight-loss medications, Qnexa and Lorqess, were rejected this year.

Contrave was said to have the least side effects of the three new agents, but also appeared to be the least effective in terms of weight loss.

Copyright 2010 ABC News Radio


FDA to Review Another Weight-Loss Pill

Photo Courtesy - Getty Images(WASHINGTON) -- The FDA on Tuesday will bring together outside experts to review another weight-loss pill -- the third this year.
Contrave is a blend of naltrexone, a drug used to help junkies and alcoholics kick the habit, and bupropion, an anti-depressant that’s also used for smoking cessation and seasonal affective disorder.
Contrave’s prospects seem no better than the last two weight-loss pills, which both were shot down by the FDA this fall.
An FDA staff review released Friday finds Contrave fell short of the agency’s weight-loss targets. And the reviewers want a study to focus specifically on the drug’s effects on the heart.
Anti-depressants can cause suicidal thoughts, but no one in the last Contrave study “completed or attempted suicide.”

Copyright 2010 ABC News Radio

ABC News Radio